Global Health Share Price
Sector:
You have to be logged in to add this to Watchlist.
Login or Register
1104.40 +36.50 (3.42%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1070.6
Today’s High
1114.7
52 Week Low
707.6
52 Week High
1513.75
1105.00 +35.60 (3.33%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1070.95
Today’s High
1115.6
52 Week Low
708
52 Week High
1513.9
Key Metrics
- Market Cap (In Cr) 29674.48
- Beta -
- Div. Yield (%) 0
- P/B 10.21
- TTM P/E 72.84
- Peg Ratio 7.25
- Sector P/E 30.05
- D/E -
- Open Price 1074
- Prev Close 1067.9
Global Health Analysis
Price Analysis
-
1 Week10.33%
-
3 Months-8.55%
-
6 Month-20.3%
-
YTD15.21%
-
1 Year41.71%
Risk Meter
- 35% Low risk
- 35% Moderate risk
- 35% Balanced Risk
- 35% High risk
- 35% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 3
- Buy
- 0
- 0
- 0
- 0
- Hold
- 3
- 3
- 3
- 4
- Sell
- 3
- 3
- 3
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 8
- 8
- 8
- 8
Global Health News
Equitas Small Finance Bank, RBL Bank & others hit 52 week low today ;Check the full list here?
3 min read . 08 Oct 2024Reliance Communications, The Anup Engineering & others hit 52 week high today ; Do you own any?
4 min read . 08 Oct 2024Q2 FY25 to see slowest earnings growth for Nifty companies in 17 quarters: MOFSL
1 min read . 07 Oct 2024Global Health Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 3275.11
- Selling/ General/ Admin Expenses Total
- 1191.2
- Depreciation/ Amortization
- 172.73
- Other Operating Expenses Total
- 525.48
- Total Operating Expense
- 2648.76
- Operating Income
- 626.35
- Net Income Before Taxes
- 627.1
- Net Income
- 478.19
- Diluted Normalized EPS
- 17.8
- Period
- 2024
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.02
- Period
- 2024
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023
- Total Revenue
- 2694.25
- Selling/ General/ Admin Expenses Total
- 1436.84
- Depreciation/ Amortization
- 149.91
- Other Operating Expenses Total
- 3.49
- Total Operating Expense
- 2215.57
- Operating Income
- 478.68
- Net Income Before Taxes
- 449.29
- Net Income
- 326.08
- Diluted Normalized EPS
- 12.59
- Period
- 2023
- Total Assets
- 4115.96
- Total Liabilities
- 1687.76
- Total Equity
- 2428.21
- Tangible Book Valueper Share Common Eq
- 90.35
- Period
- 2023
- Cashfrom Operating Activities
- 644.52
- Cashfrom Investing Activities
- -342.34
- Cashfrom Financing Activities
- 345.64
- Net Changein Cash
- 647.81
- Period
- 2022
- Total Revenue
- 2166.59
- Selling/ General/ Admin Expenses Total
- 1165.26
- Depreciation/ Amortization
- 129.71
- Other Operating Expenses Total
- 6
- Total Operating Expense
- 1843.95
- Operating Income
- 322.64
- Net Income Before Taxes
- 280.56
- Net Income
- 196.2
- Diluted Normalized EPS
- 7.25
- Period
- 2022
- Total Assets
- 3145.52
- Total Liabilities
- 1529.51
- Total Equity
- 1616.01
- Tangible Book Valueper Share Common Eq
- 60.02
- Period
- 2022
- Cashfrom Operating Activities
- 311.26
- Cashfrom Investing Activities
- -420.89
- Cashfrom Financing Activities
- 159.59
- Net Changein Cash
- 49.97
- Period
- 2021
- Total Revenue
- 1446.74
- Selling/ General/ Admin Expenses Total
- 897.85
- Depreciation/ Amortization
- 123.21
- Other Operating Expenses Total
- 4.76
- Total Operating Expense
- 1375.66
- Operating Income
- 71.08
- Net Income Before Taxes
- 32.46
- Net Income
- 28.8
- Diluted Normalized EPS
- 1.06
- Period
- 2021
- Total Assets
- 2694.1
- Total Liabilities
- 1311.76
- Total Equity
- 1382.34
- Tangible Book Valueper Share Common Eq
- 50.06
- Period
- 2021
- Cashfrom Operating Activities
- 241.77
- Cashfrom Investing Activities
- -239.15
- Cashfrom Financing Activities
- -80.72
- Net Changein Cash
- -78.1
- Period
- 2020
- Total Revenue
- 1500.42
- Selling/ General/ Admin Expenses Total
- 983.52
- Depreciation/ Amortization
- 115.04
- Other Operating Expenses Total
- 2.6
- Total Operating Expense
- 1425.97
- Operating Income
- 74.45
- Net Income Before Taxes
- 63.87
- Net Income
- 36.33
- Diluted Normalized EPS
- 1.36
- Period
- 2020
- Total Assets
- 2666.29
- Total Liabilities
- 1316.75
- Total Equity
- 1349.54
- Tangible Book Valueper Share Common Eq
- 48.79
- Period
- 2020
- Cashfrom Operating Activities
- 175.07
- Cashfrom Investing Activities
- -87.07
- Cashfrom Financing Activities
- -0.88
- Net Changein Cash
- 87.12
- Period
- 2024-06-30
- Total Revenue
- 861.08
- Selling/ General/ Admin Expenses Total
- 324.57
- Depreciation/ Amortization
- 46.62
- Other Operating Expenses Total
- 141.32
- Total Operating Expense
- 721.37
- Operating Income
- 139.7
- Net Income Before Taxes
- 143.65
- Net Income
- 106.29
- Diluted Normalized EPS
- 3.96
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 808.63
- Selling/ General/ Admin Expenses Total
- 307.64
- Depreciation/ Amortization
- 45.45
- Other Operating Expenses Total
- 127.9
- Total Operating Expense
- 674.74
- Operating Income
- 133.89
- Net Income Before Taxes
- 143.09
- Net Income
- 127.38
- Diluted Normalized EPS
- 4.74
- Period
- 2024-03-31
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.02
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023-12-31
- Total Revenue
- 832.6
- Selling/ General/ Admin Expenses Total
- 302.08
- Depreciation/ Amortization
- 43.98
- Other Operating Expenses Total
- 127.76
- Total Operating Expense
- 664.49
- Operating Income
- 168.11
- Net Income Before Taxes
- 172.36
- Net Income
- 123.64
- Diluted Normalized EPS
- 4.6
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 843.94
- Selling/ General/ Admin Expenses Total
- 296.61
- Depreciation/ Amortization
- 42.91
- Other Operating Expenses Total
- 140.9
- Total Operating Expense
- 674
- Operating Income
- 169.94
- Net Income Before Taxes
- 170.6
- Net Income
- 125.16
- Diluted Normalized EPS
- 4.66
- Period
- 2023-09-30
- Total Assets
- 4079.47
- Total Liabilities
- 1425.34
- Total Equity
- 2654.13
- Tangible Book Valueper Share Common Eq
- 98.71
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 282.6
- Cashfrom Investing Activities
- -225.51
- Cashfrom Financing Activities
- -470.37
- Net Changein Cash
- -413.28
- Period
- 2023-06-30
- Total Revenue
- 773.04
- Selling/ General/ Admin Expenses Total
- 284.39
- Depreciation/ Amortization
- 40.38
- Other Operating Expenses Total
- 129.4
- Total Operating Expense
- 635.54
- Operating Income
- 137.5
- Net Income Before Taxes
- 141.04
- Net Income
- 102.01
- Diluted Normalized EPS
- 3.8
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 703.42
- Selling/ General/ Admin Expenses Total
- 252.73
- Depreciation/ Amortization
- 37.95
- Other Operating Expenses Total
- 122.81
- Total Operating Expense
- 578.27
- Operating Income
- 125.15
- Net Income Before Taxes
- 133.08
- Net Income
- 101.07
- Diluted Normalized EPS
- 3.76
- Period
- 2023-03-31
- Total Assets
- 4115.96
- Total Liabilities
- 1687.76
- Total Equity
- 2428.21
- Tangible Book Valueper Share Common Eq
- 90.35
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 644.52
- Cashfrom Investing Activities
- -342.34
- Cashfrom Financing Activities
- 345.64
- Net Changein Cash
- 647.81
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Global Health Technical
Moving Average
SMA
- 5 Day1036.55
- 10 Day1007.74
- 20 Day1046.72
- 50 Day1092.15
- 100 Day1175.74
- 300 Day1206.9
Global Health Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- GO DIGIT GENERAL INSURANCE
- 365.15
- -1.9
- -0.52
- 407.55
- 277.8
- 33491.64
- Piramal Pharma
- 232.45
- 1
- 0.43
- 244.1
- 87.55
- 30751.93
- Global Health
- 1104.4
- 36.5
- 3.42
- 1513.75
- 707.6
- 29649.54
- Emcure Pharmaceuticals
- 1479.2
- 0.15
- 0.01
- 1577.5
- 1226.5
- 27971.43
- Five Star Business Finance
- 901.05
- 6.6
- 0.74
- 903.2
- 601
- 26351.14
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- GO DIGIT GENERAL INSURANCE
- 185.76
- 8.89
- -3.12
- -1.75
- Piramal Pharma
- 503.29
- 3.87
- -
- -
- Global Health
- 60.15
- 9.88
- -
- -
- Emcure Pharmaceuticals
- 56
- 9.49
- 19.6
- 7.81
- Five Star Business Finance
- 30.02
- 5.04
- 16.12
- 37
Global Health Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 08-Aug-24
- Quarterly Results
- 17-May-24
- Audited Results
- 08-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 20-Sept-23
- 10-Aug-23
- AGM